REXULTI 0.25 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Brexpiprazole
- Strength
- 0.25 mg
- Form
- tablet
- ATC code
- N05AX16
- Registered in
- Canada · Otsuka Pharmaceutical Co Ltd
- Prescription
- Prescription only
- DIN
- 02461749
Source: Drug Product Database · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
United States 2 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Brexpiprazole | .25 mg · Tablet | Prescription only | Ajanta Pharma USA Inc. | 27241-204 |
| Rexulti | .25 mg · Tablet | Prescription only | Otsuka America Pharmaceutical, Inc. | 59148-035 |
Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.
Netherlands 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| RXULTI 0 | 0,25 mg · filmomhulde tablet | Prescription only | Otsuka Pharmaceutical Netherlands B.V. | EU/1/18/1294 |
Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.
Same active substance, but no match for this strength and form
- European Union: 1 products · Every strength and form
- Spain: 5 products · Every strength and form
- Switzerland: 5 products · Every strength and form